Literature DB >> 15917297

Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation.

Joseph Krueger1, Fan-Li Chou, Angela Glading, Erik Schaefer, Mark H Ginsberg.   

Abstract

Cell cycle progression is dependent on the nuclear localization and transcriptional effects of activated extracellular signal-regulated kinase (ERK)1 and ERK2 mitogen-activated protein (MAP) kinases (ERK1/2). Phosphoprotein enriched in astrocytes (PEA-15) binds ERK1/2 and inhibits their nuclear localization, thus blocking cell proliferation. Here, we report that phosphorylation of PEA-15 blocks its interaction with ERK1/2 in vitro and in vivo and that phosphorylation of both Ser104 and Ser116 is required for this effect. Using phosphomimetic and nonphosphorylatable mutants of PEA-15, we found that PEA-15 phosphorylation abrogates its capacity to block the nuclear localization and transcriptional activities of ERK1/2; this phosphorylation therefore enables the proliferation of cells that express high levels of PEA-15. Additionally, we report that PEA-15 phosphorylation can modulate nontranscriptional activities of ERK1/2, such as the modulation of the affinity of integrin adhesion receptors. Finally, we used a novel anti-phospho-specific PEA-15 antibody to establish that PEA-15 is phosphorylated in situ in normal mammary epithelium. These results define a novel posttranslational mechanism for controlling the subcellular localization of ERK1/2 and for specifying the output of MAP kinase signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917297      PMCID: PMC1182297          DOI: 10.1091/mbc.e04-11-1007

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  42 in total

1.  Identification of a novel, alternatively spliced isoform and single nucleotide polymorphisms in the murine Pea-15 gene.

Authors:  D A Underhill; K J Vogan; T M Underhill; P Gros
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

2.  PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.

Authors:  E Formstecher; J W Ramos; M Fauquet; D A Calderwood; J C Hsieh; B Canton; X T Nguyen; J V Barnier; J Camonis; M H Ginsberg; H Chneiweiss
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

3.  Proteins linked to a protein transduction domain efficiently transduce pancreatic islets.

Authors:  J Embury; D Klein; A Pileggi; M Ribeiro; S Jayaraman; R D Molano; C Fraker; N Kenyon; C Ricordi; L Inverardi; R L Pastori
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

Review 4.  Keeping TNF-induced apoptosis under control in astrocytes: PEA-15 as a 'double key' on caspase-dependent and MAP-kinase-dependent pathways.

Authors:  D Zvalova; E Formstecher; M Fauquet; B Canton; H Chneiweiss
Journal:  Prog Brain Res       Date:  2001       Impact factor: 2.453

5.  Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism.

Authors:  J W Ramos; P E Hughes; M W Renshaw; M A Schwartz; E Formstecher; H Chneiweiss; M H Ginsberg
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

6.  Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action.

Authors:  Alessandra Trencia; Anna Perfetti; Angela Cassese; Giovanni Vigliotta; Claudia Miele; Francesco Oriente; Stefania Santopietro; Ferdinando Giacco; Gerolama Condorelli; Pietro Formisano; Francesco Beguinot
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

7.  Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.

Authors:  G Dong; E Loukinova; Z Chen; L Gangi; T I Chanturita; E T Liu; C Van Waes
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

8.  Differential gene expression by endothelial cells in distinct angiogenic states.

Authors:  J Glienke; A O Schmitt; C Pilarsky; B Hinzmann; B Weiss; A Rosenthal; K H Thierauch
Journal:  Eur J Biochem       Date:  2000-05

Review 9.  Role of MAP kinase in tumor progression and invasion.

Authors:  Kaladhar B Reddy; Sanaa M Nabha; Natasha Atanaskova
Journal:  Cancer Metastasis Rev       Date:  2003-12       Impact factor: 9.264

10.  Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.

Authors:  C Hao; F Beguinot; G Condorelli; A Trencia; E G Van Meir; V W Yong; I F Parney; W H Roa; K C Petruk
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

View more
  34 in total

1.  Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.

Authors:  Yosuke Watanabe; Fumiyuki Yamasaki; Yoshinori Kajiwara; Taiichi Saito; Takeshi Nishimoto; Chandra Bartholomeusz; Naoto T Ueno; Kazuhiko Sugiyama; Kaoru Kurisu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

2.  MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model.

Authors:  Chandra Bartholomeusz; Tetsuro Oishi; Hitomi Saso; Ugur Akar; Ping Liu; Kimie Kondo; Anna Kazansky; Savitri Krishnamurthy; Jangsoon Lee; Francisco J Esteva; Junzo Kigawa; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2011-12-05       Impact factor: 6.261

3.  The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling.

Authors:  Sandra Pastorino; Hemamalini Renganathan; Maisel J Caliva; Erin L Filbert; John Opoku-Ansah; Florian J Sulzmaier; Joanna E Gawecka; Guy Werlen; Andrey S Shaw; Joe W Ramos
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

4.  A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells.

Authors:  Irene Hunter; Keith S Mascall; Joe W Ramos; Graeme F Nixon
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

5.  ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.

Authors:  Hema Vaidyanathan; John Opoku-Ansah; Sandra Pastorino; Hema Renganathan; Michelle L Matter; Joe W Ramos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

6.  Kinetics of regulatory serine variants of tyrosine hydroxylase with cyclic AMP-dependent protein kinase and extracellular signal-regulated protein kinase 2.

Authors:  Montserrat Royo; S Colette Daubner
Journal:  Biochim Biophys Acta       Date:  2006-02-14

7.  Alterations in the cerebellar (Phospho)proteome of a cyclic guanosine monophosphate (cGMP)-dependent protein kinase knockout mouse.

Authors:  Eleonora Corradini; Raghavan Vallur; Linsey M Raaijmakers; Susanne Feil; Robert Feil; Albert J R Heck; Arjen Scholten
Journal:  Mol Cell Proteomics       Date:  2014-06-12       Impact factor: 5.911

8.  Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells.

Authors:  Mirna Mourtada-Maarabouni; Gwyn T Williams
Journal:  Leuk Res       Date:  2009-06-18       Impact factor: 3.156

9.  DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.

Authors:  Anita C Bellail; Margaret C L Tse; Jin H Song; Surasak Phuphanich; Jeffrey J Olson; Shi Yong Sun; Chunhai Hao
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

10.  Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha.

Authors:  Jacob R Haling; Fen Wang; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.